Remicade (Infliximab)

Welcome to the Remicade (Infliximab) social portal on PsoriasisPatients.com.

This page will connect you with all activities and content on our site that is, in one way or another, related to the Remicade treatment. You can get access to blog entries, participate in discussion forums, view our members' treatment journals, answer opinion polls, help to answer questions or ask your own, enrol in a dedicated support group, as well as connect with people who have experience with the Remicade treatment. The resources section is also available where you can get more information about the drug as well as recommend other helpful Remicade resources. You may want to start with the basic info about this treatment below:

Drug name: Remicade® (Infliximab)

How does Remicade work?

Remicade binds to TNF molecules in the blood and tissues in the psoriatic plaques and inhibits the activation of cell receptors that trigger the inflammatory symptoms seen in psoriasis.

Who is a good candidate for Remicade?

Remicade is recommended for adults (over the age of 18) with extremely severe and resistant psoriasis. It is the most potent drug available for the treatment of psoriasis.

What are the advantages of Remicade?

Remicade is extremely powerful, and is often effective in treating resistant psoriasis that does not respond to other therapies. It takes effect quickly, usually within two weeks with maximum benefit at 10 weeks.

What are possible side-effects?

The most common side-effects include flu-like symptoms, and rashes. A doctor should be monitoring you on a regular basis to ensure safety and treatment efficacy.

Are there any other concerns?

This treatment must often be taken in conjunction with Methotrexate to prevent your body from building an antibody to this drug, which will weaken its effects.

Need More information?

Please note that this is a very brief and basic introduction to the Remicade treatment. For detailed information about Remicade, or studies related to Remicade please look at the Remicade Resources page.